Jurisdictions that have used 90% of their JYNNEOS monkeypox vaccine supply and are administering the vaccine intradermally to adults can begin ordering additional vaccine Monday, when the Department of Health and Human Services will release an additional 1.8 million doses to administer to high-risk individuals, the White House announced today. HHS also will set aside 50,000 vaccine doses from the Strategic National Stockpile for jurisdictions hosting large events that attract gay, bisexual and other men who have sex with men, who are at higher risk for the virus; and allocate 50,000 treatment courses of the investigational antiviral drug TPOXX to jurisdictions based on their case count and risk. To stretch available supply of the vaccine five-fold, the Food and Drug Administration last week issued an emergency use authorization allowing health care providers to administer the vaccine to adults intradermally.

Related News Articles

Headline
As summer Pride parades and other large gatherings approach, Americans at high risk for mpox (monkeypox) exposure should ensure they are fully vaccinated with…
Headline
The Food and Drug Administration Friday authorized for emergency use a molecular test to detect mpox (formerly known as monkeypox) at the point of care in…
Headline
The Food and Drug Administration Friday authorized for emergency use a real-time polymerase chain reaction test to detect mpox (formerly known as…
Headline
In a study of men under age 50 who were eligible to receive the JYNNEOS vaccine to prevent monkeypox (mpox) during the U.S. outbreak this year, unvaccinated…
Headline
The World Health Organization today recommended a new name for monkeypox that is intended to mitigate a rise in related racist and stigmatizing language…
Headline
The Department of Health and Human Services today renewed the nation’s monkeypox public health emergency declaration for another 90 days. When the PHE was…